Pfizer Stock News

Americans will be able to get COVID-19 antiviral pills for free if they test positive at a pharmacy, President Joe Biden has said. Chris Sweda/Chicago Tribune/Tribune News…

"If you get COVID-19, the Pfizer pill reduces your chances of ending up in the hospital by 90%," President Biden said in his State of the Union address.

Investors are well-positioned due to the rollout of the Paxlovid anti-viral drug, which should become the COVID treatment of choice in the Western world.

Shares of Pfizer Inc. gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (RSV) vaccine had received a breakthrough therapy designation from the Food and Drug Administration. The vaccine candidate is being evaluated in pregnant women to see if it can prevent illness among infants up to until the age of 6 months old. Several drug makers are developing RSV vaccines, including Moderna Inc. and GlaxoSmithKline , though GSK this week halted a study assessing its investigational RSV shot in pregnant women, saying it needs to better understand the safety data. Pfizer''s stock has gained 36.5% over the past year, while the broader S&P 500 is up 10.3%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

The U.S. Food and Drug Administration ((FDA)) granted breakthrough therapy designation to Pfizer (PFE) respiratory syncytial virus ((RSV)) vaccine candidate PF-06482077 or RSVpreF,…

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06482077 or RSVpreF, received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for prevention of RSV-associated lower respiratory tract illness in infants from birth up to six months of age by active immunization of pregnant women. The FDA decision is informed by the results of the Phase 2b proof-of-concept study of RSVpreF (NCT0403209

March 1, 2022 -- You would possibly perhaps well also merely absorb already considered the headline: The Pfizer vaccine’s effectiveness against COVID-19 an infection drops to 12% in 5- to 11-year-olds. But how attain consultants interpret this and numerous outcomes from this preprint be conscious? Despite the findings, which absorb no longer been peep-reviewed, researchers…

The coronavirus vaccine developed by Pfizer and BioNTech for use in young children provided substantial protection against hospitalization, but its ability to protect against infection declined rapidly among children ages 5 to 11 compared to older age groups, a new study finds . The study, conducted by the state Department of Health and University at Albany School of Public Health, relied on a large set of pediatric vaccination, case and hospitalization data collected throughout December and January — when the omicron variant was at its height in New York. It was published Monday — just one day after Gov. Kathy Hochul announced the state would be ending its in-school mask mandate — on medRxiv as a preprint and has not yet undergone peer review. “The data are not surprising as the vaccine was developed in response to an earlier COVID-19 variant and reduced effectiveness of two doses against the omicron variant has been seen to some degree with all vaccines and ages,” state Health Commissioner Dr.

In a media roundtable, regional leaders from Pfizer in Africa and the Middle East region (AfME) announced on Tuesday, March 1, 2022, their plans for delivering breakthroughs to more patients across the region, aiming to impact more than 45 percent more people in 2022 versus 2021. The company will continue to play a leading role in the global fight against COVID-19 while having more than 50 product launches across AfME, thereby addressing unmet needs and critical public health challenges. Continue reading Pfizer Announces Goal of Delivering Breakthroughs To More Patients In 2022, Reinforcing Commitment To Address Unmet Needs at BizWatchNigeria.Ng.

Editor''s modern: Net the most up-to-date COVID-19 news and steering in Medscape''s Coronavirus Resource Heart. You might perhaps perhaps private already considered the headline — Pfizer''s vaccine effectiveness towards COVID-19 an infection drops to 12% in 5- to 11-year-olds — but how blueprint consultants interpret this and other results from this pre-print seek? Despite…

President Joe Biden said in his State of the Union address that Americans who test positive for COVID-19 would soon have access to Pfizer’s antiviral therapy at no cost to them through a new treatment program.

The vaccine''s efficacy against infection among those children declined to 12 per cent at the end of January from 68 per cent in mid-December compared to kids who did not get vaccinated The post Pfizer/BioNTech COVID vaccine less effective in kids aged five to 11 years: New York study appeared first on Express Pharma .

Many of Greene''s utterances were inaudible to reporters, such as when she yapped something in Biden''s direction when he spoke about ordering antiviral pills from Pfizer to treat COVID-19.

The text of President Joe Biden''s State of the Union address, as provided by the White House:Madam Speaker, Madam Vice President, our First Lady and Second Gentleman. Members of Congress and the Cabinet. Justices of the Supreme Court. My fellow Americans.Last year COVID-19 kept us apart. This year we are finally together again. Tonight, we meet as Democrats Republicans and Independents. But most importantly as Americans. With a duty to one another to the American people to the Constitution. And with an unwavering resolve that freedom will always triumph over tyranny.Six days ago, Russia''s Vladimir Putin sought to shake the foundations of the free world thinking he could make it bend to his menacing ways. But he badly miscalculated. He thought he could roll into Ukraine and the world would roll over.Instead he met a wall of strength he never imagined. He met the Ukrainian people. From President Zelenskyy to every Ukrainian, their fearlessness, their courage, their determination, inspires the world.

AS PREPARED FOR DELIVERY Madam Speaker, Madam Vice President, our First Lady and Second Gentleman. Members of Congress and the Cabinet. Justices of the Supreme Court. My fellow Americans. Last year COVID-19 kept us apart. This year we are finally together again. Tonight, we meet as Democrats Republicans and Independents. But most importantly as Americans. With a duty to one another to the American people to the Constitution. And with an unwavering resolve that freedom will always triumph over tyranny. Six days ago, Russia’s Vladimir Putin sought to shake the foundations of the free world thinking he could make it bend to his menacing ways. But he badly miscalculated. He thought he could roll into Ukraine and the world would roll over. Instead he met a wall of strength he never imagined. He met the Ukrainian people. From President Zelenskyy to every Ukrainian, their fearlessness, their courage, their determination, inspires the world. Groups of citizens blocking tanks with their bodies.